Nursing Homes Underreport Antipsychotic Use but Overreport Diagnoses Qualifying for Appropriate Use.

ABSTRACT: Antipsychotic drug use in U.S. nursing homes remains a priority concern, but less is understood about the characteristics associated with reporting. Using linked Medicare claims and Minimum Data Set (MDS) assessments for long-stay nursing home residents from January 2018 to December 2019, we assessed the consistency of antipsychotic drug reporting and diagnosis of conditions (schizophrenia, Tourette's syndrome, and Huntington's disease) which qualify as appropriate drug use across data sources by calculating reporting rates in facility-reported MDS and Medicare claims. The antipsychotic reporting outcome is conditional on claims reporting while the condition reporting outcomes are conditional on MDS reporting. We found underreporting (87% reporting rate) in facility-reported antipsychotic

SUBMITTER: Chen AC 

PROVIDER: S-EPMC10846688 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature